> 30 manufacturing sites globally
> 300 million
patients reached worldwide in 2025
> 20 billion treatments produced in 2025
The reliability and strength of the network are constantly put to the test. During the major snowstorm that hit the US in January 2026, for example, air and ground transport were disrupted across the country. The RLT team responded quickly to keep operations moving, maintaining the company’ s very high service levels.
“ It’ s a very different way of working and no easy feat,” Steffen says,“ but as pioneers in the space and proven medicines on the market in multiple cancers we continue to deliver with the aim to go even further, expanding into other cancers in the future. This requires an incredible amount of skill,